BOCI Research: Maintains a "buy" rating on POLY PPT SER (06049) and lowers the target price to HK$51.71.
Given its strong cash flow, strong support from the parent company, and unique competitiveness in the non-residential sector, the bank expects Poly Property's basic property management income growth rate to reach 15%.
BOCI Research released a report stating that it maintains a "buy" rating for POLY PPT SER (06049), with a target price lowered to HK$51.71. It is projected that the company's revenue will increase by 9% in the fiscal year 2024 and core net profit will grow by 4.8%. At the same time, the forecast for core earnings per share for the fiscal year 2024 has been reduced by 3.9%. The bank points out that the forecast for the fiscal year 2024 revenue of POLY PPT SER has been lowered by 1.5%, mainly due to the impact of economic growth slowdown on community value-added service revenue and gross profit margin. Additionally, the bank expects that POLY PPT SER's basic property management revenue growth rate will reach 15% target, considering its strong cash flow, strong support from its parent company, and unique competitiveness in non-residential areas.
Related Articles

Humanwell Healthcare (600079.SH): RFUS-1646 tablets obtained the Drug Clinical Trial Approval Notification.

Switzerland plans to refine UBS Group AG's capital new regulations or influence the future and headquarters selection of banks.

Jinyu Bio-Technology's subsidiary has been approved to produce emergency foot-and-mouth disease vaccines for immunization.
Humanwell Healthcare (600079.SH): RFUS-1646 tablets obtained the Drug Clinical Trial Approval Notification.

Switzerland plans to refine UBS Group AG's capital new regulations or influence the future and headquarters selection of banks.

Jinyu Bio-Technology's subsidiary has been approved to produce emergency foot-and-mouth disease vaccines for immunization.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


